Article
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.
Nature communications - 21 Nov 2025
Corbett Ryan J, Kaufman Rebecca S, McQuaid Shelly W, Vaksman Zalman, Phul Saksham, Brown Miguel A, Mason Jennifer L, Waszak Sebastian M, Zhang Bo, Zhong Chuwei, Blauel Emily, Desai Heena, Hausler Ryan, Naqvi Ammar S, Daggett Jessica M, Sickler Alex, Cresswell-Clay Evan C, Sullivan Patricia J, Chroni Antonia, Geng Zhuangzhuang, Gonzalez Elizabeth M, Zhu Yuankun, Heath Allison P, Li Marilyn, Storm Phillip B, Resnick Adam C, Maxwell Kara N, Cole Kristina A, Waanders Angela J, Bornhorst Miriam, MacFarland Suzanne P, Rokita Jo Lynne, Diskin Sharon J
Abstract excerpt
The contribution of rare pathogenic/likely pathogenic (P/LP) germline variants to pediatric central nervous system (CNS) tumor development remains understudied. Here, we characterize the prevalence and biological significance of germline P/LP variants in cancer predisposition genes across 830 CNS tumor patients from the Pediatric Brain Tumor Atlas (PBTA). We identify germline P/LP variants in 23.3% (193/830) of...
Topics
- Humans
- Germ-Line Mutation
- Central Nervous System Neoplasms
- Child
- Genetic Predisposition to Disease
- Male
- Female
